D4DPR Updates

D4DPR Op-ed "Doctors prescribing heroin? One of two bold moves to curb overdose deaths"

D4DPR on Decriminalizing Use and Personal Possession of Psychedelics

D4DPR Position Paper on "State-level Decriminalization of Personal Use and Simple Possession of Psychedelics"

D4DPR 2025 Membership Drive Underway

Dr. Tanya Adams leaving D4DPR Board

D4DPR Position Paper on "Safer Supply Strategies for Opioid Use Disorder Treatment"

Newsletter Archives

Following D4DPR's Petition Challenging the DEA's Participant Selection Process for the Cannabis Rescheduling Hearing

D4DPR Position Paper on "Prioritizing Opioid Settlement Funds for Overdose Prevention Centers"

Welcoming New D4DPR Board of Directors Members

D4DPR Webinar: The Farm Bill, Hemp-derived Minor Cannabinoids, and Regulatory Mayhem

Announcing Changes to the D4DPR Board of Directors

D4DPR requests a hearing with the DEA in the matter of “Schedules of Controlled Substances: Rescheduling of Marijuana”

D4DPR Webinar: Support. Don't Punish. Global Day of Action: A Health-Focused Approach to Drug Use and Misuse

D4DPR Position Paper on "The Importance of Descheduling, Not Just Rescheduling, Cannabis in the U.S."

Press Release: Doctors for Drug Policy Reform Applauds Progress in Ending Cannabis Prohibition

D4DPR Position Paper on "Recommendations for Regulating Semi-Synthetic Intoxicating Cannabinoids Derived from Hemp"

D4DPR/Plant Medicine Law Group Webinar: Navigating the Legal Psychedelics Path

Op-Ed: "Supporting Adult Use Regulation in Hawaii"

Press Release: Doctors for Cannabis Regulation Rebrands as Doctors for Drug Policy Reform

D4DPR Organize Major Support for Universal Adoption of International Cannabis Product Symbol

Press Release: D4DPR Organize Major Support for Universal Adoption of International Cannabis Product Symbol

Op-Ed: "New York’s ‘Symbolic’ Failure In Cannabis Regulation"

ASTM International and Doctors for Drug Policy Reform Sign Memorandum of Understanding

D4DPR/Marijuana Matters Joint Webinar: Cannabis and Women's Health

D4DPR and 85 Other Groups Send Letter to Biden Administration on 4/20

"Seeing Through the Smoke" Available Now

D4DPR Publishes White Paper on Legislating Cannabis Use in Healthcare Facilities

Doctors for Drug Policy Reform Gathers Support for New York State to Adopt Universal Cannabis Product Symbol

Doctors for Drug Policy Reform Welcomes Tanya Adams to our Board of Directors

Doctors for Drug Policy Reform Urges the United States Federal Government to Prioritize the Immediate Release of Brittney Griner from Detention in Russia

Doctors for Drug Policy Reform welcomes Alexis Isaacs to our Board of Directors

D4DPR Supports the “Cannabidiol and Marihuana Research Expansion Act”

D4DPR Announces New Board Member Tanja Bagar, PhD

Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD

Montana Adopts the International Intoxicating Cannabis Product Symbol (IICPS)

Godfrey Pearlson M.D.: Weed Science

Cannabis Task Force Prepares Report, Proposals for Council

D4DPR Announces Dr. Bryon Adinoff as President

D4DPR Welcomes Adriana Kertzer to its Board of Directors

Dr. Donald Lyman on what D4DPR represents

D4DPR Celebrates 5 Years

Doctors for Drug Policy Reform Statement on Cannabis Use During Pregnancy and Breastfeeding

D4DPR Announces the Appointment of Dr. Rachel Knox to the Board of Directors

D4DPR Cautions Against Smoking and Vaping During the COVID-19 Pandemic

D4DPR and others call for the cease of cannabis arrests and release of incarcerated cannabis offenders in light of COVID-19

D4DPR and others urge governors and legislative leaders to preserve and ensure cannabis access amid social distancing

Position Statement on Medical Cannabis and the Federal Government

An Open Letter to the National Football League